UAE Women's Health Market Analysis Report 2022 to 2030

UAE Women's Health Market Analysis

$ 3999

UAE Women’s Health Market is projected to grow from $200 Mn in 2022 to $314 Mn by 2030, registering a CAGR of 5.80% during the forecast period of 2022-30. The UAE women's health market is expected to grow in the coming years, driven by factors such as an aging population, increased awareness of women's / issues, and government initiatives to promote women's health. There are some of the major companies operating in the UAE women's health market include pharmaceutical giants such as Pfizer and Roche, AstraZeneca.

ID: IN10AEPH026 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Shivam Zalke

Buy Now

UAE Women’s Health Market Executive Summary

UAE Women’s Health Market is projected to grow from $200 Mn in 2022 to $314 Mn by 2030, registering a CAGR of 5.80% during the forecast period of 2022-30.

The pharmaceutical market in the United Arab Emirates (UAE) is expected to experience significant growth in the coming years, driven by factors such as an aging population, increasing prevalence of chronic diseases, and rising healthcare expenditure. The market is segmented into prescription drugs and over-the-counter (OTC) drugs, with the prescription drugs segment accounting for a larger share of the market. The market is also segmented by therapeutic area, with cardiovascular drugs and diabetes drugs being the largest segments.

The government is actively working to improve the healthcare infrastructure in the UAE and increase healthcare expenditure, which is expected to drive the growth of the pharmaceutical market. Additionally, the presence of a large number of international and local pharmaceutical companies in the UAE, along with the availability of advanced medical technologies, is also expected to drive market growth. However, the market may face some challenges such as price controls, regulatory changes, and reimbursement issues.

The United Arab Emirates (UAE) women's health market is expected to experience significant growth in the coming years, driven by factors such as an increasing population of women, rising awareness about health and wellness, and the availability of advanced medical technologies. The market is segmented into gynecology, obstetrics, and fertility, and is expected to be driven by the gynecology segment, which is anticipated to grow at the highest CAGR during the forecast period. The increasing prevalence of gynecological cancers, such as cervical and ovarian cancer, is expected to drive the market growth. Additionally, the government's efforts to improve healthcare infrastructure and increase healthcare expenditure are also expected to positively impact the market.

uae women's health market analysis

Market Dynamics

Market Growth Drivers

The key drivers of the United Arab Emirates (UAE) women's health market include:

The increasing population of women: The increasing number of women in the UAE is expected to drive market growth as it leads to an increase in the number of women who require healthcare services.
Rising awareness about health and wellness: The growing awareness about health and wellness among women in the UAE is expected to drive market growth as it leads to an increase in the number of women who seek healthcare services.
Availability of advanced medical technologies: The availability of advanced medical technologies in the UAE is expected to drive market growth as it leads to an increase in the number of women who can access healthcare services.
Government efforts to improve healthcare infrastructure: The government's efforts to improve healthcare infrastructure and increase healthcare expenditure in the UAE are expected to drive market growth as it leads to an increase in the number of women who can access healthcare services.
Prevalence of gynecological cancers: The increasing prevalence of gynecological cancers such as cervical and ovarian cancer is expected to drive market growth as it leads to an increase in the number of women who require healthcare services.

Competitive Landscape

Key Players

Some of the key players in the United Arab Emirates (UAE) women's health market include:

Johnson & Johnson: A global healthcare company that offers a wide range of products and services for women's health, including gynecological and obstetric products.
Pfizer: A global pharmaceutical company that offers a wide range of products and services for women's health, including hormonal therapy, contraceptives, and fertility treatments.
Novo Nordisk: A global healthcare company that offers a wide range of products and services for women's health, including diabetes treatments and hormonal therapy.
Roche: A global healthcare company that offers a wide range of products and services for women's health, including cancer treatments and diagnostic products.
Merck: A global healthcare company that offers a wide range of products and services for women's health, including vaccines, hormonal therapy, and cancer treatments.
AstraZeneca: A global healthcare company that offers a wide range of products and services for women's health, including cancer treatments and diagnostic products. ne replacement therapy, and menopause treatment.

These are some of the major players in the pharma UAE women's health market, there are other local and regional companies that also play important roles.

Healthcare Policies and Regulatory Landscape

The United Arab Emirates (UAE) has a well-developed healthcare system, with several policies and regulations in place to ensure the provision of high-quality healthcare services to its citizens.

Universal healthcare coverage: The government of UAE provides universal healthcare coverage to its citizens, which includes coverage for women's health services.
Healthcare infrastructure development: The government of UAE is actively working to improve the healthcare infrastructure in the country, which includes the construction of new hospitals and clinics and the expansion of existing ones.
Healthcare expenditure: The government of UAE is increasing its healthcare expenditure to improve the healthcare system and provide better healthcare services to its citizens.
Health regulations: The Ministry of Health and Prevention (MOHAP) is responsible for regulating the healthcare system in the UAE. It sets guidelines and standards for healthcare providers and facilities to ensure the provision of high-quality healthcare services.
Medical Tourism: The UAE government is also encouraging medical tourism to attract patients from all over the world.

In conclusion, the government of UAE has implemented several policies and regulations to ensure the provision of high-quality healthcare services to its citizens, including women's health services. This is expected to drive the growth of the women's health market in the country.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Women's Health Market Segmentation

By Product Type (Revenue, USD Billion):

Devices
Drugs

By Application (Revenue, USD Billion):

Contraceptives
Postmenopausal Osteoporosis
Hormonal Infertility
Menopause
Endometriosis
Polycystic Ovary Syndrome (PCOS)
Others

By End-Users (Revenue, USD Billion):

Hospitals & Clinics
Obstetrics & Gynaecology Centers
Ambulatory Surgical Centers
Research Institutes
Others

By Drug (Revenue, USD Billion):

EVISTA
XGEVA
Prolia
Mirena
Zometa
Reclast/Aclasta
Minastrin 24 Fe
NuvaRing
FORTEO
Premarin
ACTONEL
ORTHO TRI-CY LO (28)

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.